Skip to main content

Peer Review reports

From: Ruxolitinib plus standard of care in severe hospitalized adults with severe fever with thrombocytopenia syndrome (SFTS): an exploratory, single-arm trial

Original Submission
27 Dec 2023 Submitted Original manuscript
15 Jan 2024 Reviewed Reviewer Report
23 Jan 2024 Reviewed Reviewer Report - Anselm Jorda
29 Feb 2024 Author responded Author comments - Sai Wen
Resubmission - Version 2
29 Feb 2024 Submitted Manuscript version 2
3 Mar 2024 Reviewed Reviewer Report - Anselm Jorda
5 May 2024 Author responded Author comments - Sai Wen
Resubmission - Version 3
5 May 2024 Submitted Manuscript version 3
Publishing
9 May 2024 Editorially accepted
20 May 2024 Article published 10.1186/s12916-024-03421-z

You can find further information about peer review here.

Back to article page